Merck announces recipients of €1 million Grant for Multiple Sclerosis Innovation at ECTRIMS 2017
|
26 October 2017 |
Merck brings customers closer to gene therapy product commercialization
|
19 October 2017 |
Merck set to join forces with Project Data Sphere to pioneer Global Oncology Big Data Alliance
|
11 September 2017 |
Merck collaborates with angiex to speed clinical readiness of new cancer therapy
|
29 August 2017 |
Merck Biopharma Innovation Cup 2017
|
17 July 2017 |
Merck awards €1.25 million to research projects through its 2017 Grant for Fertility Innovation (GFI)
|
05 July 2017 |
Merck Foundation established
|
22 June 2017 |
Merck Ventures creates new immuno-oncology company iOnctura
|
20 June 2017 |
Anyone can become more curious. Is that true?
|
31 May 2017 |
100 healthy years - are kids prepared?
|
19 May 2017 |
Merck acquires Grzybowski Scientific Inventions to expand chemical synthesis offering
|
09 May 2017 |
Merck divests Biosimilars business to Fresenius
|
25 April 2017 |
Merck partners with University of California, San Diego (UCSD) to fight Neglected Tropical Diseases
|
20 April 2017 |
Merck advances R&D strategy through unique development model with Avillion for Anti IL-17 A/F Nanobody
|
30 March 2017 |
Merck Accelerator hits new peak of applications
|
21 March 2017 |
Cladribine tablets significantly reduced brain atrophy in patients with multiple sclerosis
|
09 February 2017 |
Merck announces research collaboration with Domain Therapeutics in immuno-oncology
|
23 January 2017 |
Merck drives business opportunities in the U.S. to foster innovation across all three business sectors
|
13 January 2017 |
Merck wins R&D 100 Award for top invention
|
11 November 2016 |
Merck invests € 250 million in production value chain in China
|
04 November 2016 |